English: Simplified graphical representation of a cross-section of the Hepatitis B virus particle and surface (surplus) antigen, the hepatitis B e antigens (HBcAg) shown are considered not part of the viral particle (quod videviral nonstructural protein). The structure of the Hepatitis B virus as first described by Dane & al.[1] and Jokelainen, Krohn & al.[2] during 1970. The hepatitis B virion is a complex, double shelled, spherical particle with a 42 nm diameter.[1][2][3]
The 6 nm[2] thick outer viral envelope or membrane contains host-derived lipids and surface proteins,[2] known collectively as HBsAg.[3] The membrane contains globular subunits each measuring ca. 3 to 4 nm in diameter and 3 to 4 nm apart.[2]
Within the membrane sphere is a 2 nm thick icosahedralnucleocapsid inner core composed of protein (HBcAg) with a 27 nm diameter.[2] When viewed through an electron microscope the inner core may appear pentagonal or hexagonal,[2] depending on the relative position of the sample.
The nucleocapsid contains a viral genome[2] of circular, partially double stranded DNA[3] and endogenous DNA polymerase[4][3] within a diameter of ca. 18 nm.[2]
The virion was initially referred to as the Dane particle.[4] Only after Baruch Blumberg received the Nobel Prize in Medicine during 1976 was it universally accepted that the particle is a virus and the infectious agent of Hepatitis B.
Australiaantigen (HBsAg): The serum of infected patients contain small spherical and rod-shaped particles with a diameter of ca. 20 nm,[5] consisting of surplus virus-coat material containing the HBsAg antigen.[1][2] This antigen was first discovered by Baruch Blumberg during 1965 within the blood of Australian aboriginal people and initially known as "Australia antigen".[6] It was shown to be associated with "serum hepatitis" by A. M. Prince during 1968.[7]
The outer membrane of the virion is sometimes extended as a tubular tail on one side of the virus particle (not shown);[2][3] these virion "tails" are identical to the small particles.[2][3]
هذه biology الصورة / الصورتان باستعمال رسومات متجهية ملفات رسوميات شعاعية.
It is recommended to name the SVG file "Hepatitis B virus v2.svg" - then the template Vector version available (or Vva) does not need the new image name parameter.
إِذا لم يكن النِّطاق العام مُمكِناً مِن النَّاحية القانونيَّة:
يَمنح المُؤَلِّف TimVickers أَيَّ شخصٍ الحقَّ في استخدام هذا العمل لأَي سببٍ كان'، دون أَي شروطٍ من قبله، ويسري هذا ما لم يكن هُناك أَحكامٌ إِضافيَّة ينصُّ عليها القانون.
سجلُّ الرَّفع الأصيل
صفحة الوصف الأصلية كانت هنا، تشير جميع أسماء المستخدمين التالية إلى en.wikipedia.
2007-11-14 18:14 TimVickers 843×577× (81917 bytes) Simplified drawing of the Hepatitis B virus particle and surface (surplus) antigen
Sources
↑ abcD.S. Dane , C.H. Cameron , Moya Briggs (1970). "Virus-Like Particles in Serum of Patients with Australia-Antigen-Associated Hepatitis". The Lancet295: 695–698. DOI:10.1016/S0140-6736(70)90926-8.
↑ abAlmeida J D, Rubenstein D & Scott E J. (1971). "New antigen-antibody system in Australia-antigen-positive hepatitis". The Lancet298 (7736): 1225–7. DOI:10.1016/S0140-6736(71)90543-5.
↑Bayer, M. E., B. S. Blumberg, and B. Werner (1968). "Particles associated with Australia antigen in the sera of patients with leukemia, Down's syndrome and hepatitis.". Nature (London)218: 1057-1059.